VSY Biotechnology, leading ophthalmic and orthopedic medical device and biotechnology company, announces the appointment of Nagihan ŞENGÜL KARPUZ to the company’s Board of Directors. Nagihan Şengül Karpuz has been appointed Board Member of VSY Biotechnology. She began her carrier at E&Y and has spent most of her career at Yıldız Holding, working in various areas […]
continue reading
VSY Biotechnology announces the launch of the Enova® C Haptic Model IOL. Enova® is the first and only 100% Glistening-Free, Dry-Packed hydrophobic acrylic IOL. Moreover, no warming or special conditioning is required before surgery! VSY Biotechnology Launches Enova® 100% Glistening-Free Hydrophobic Acrylic IOL in C Haptic Model. The unique composition of Enova® material allows uniform hydration […]
continue reading
VSY Biotechnology, leading ophthalmic and orthopedic medical device and biotechnology company, announces the appointment of seasoned executive leader Can Ongen to the company’s Board of Directors. In this role, Can Ongen will also lead VSY Biotechnology’s sales and marketing activities with a view to further strengthening the company’s position worldwide. Can brings over 25 years […]
continue reading
VSY Biotechnology GmbH, an innovation-driven company with its progressive R&D activities in ophthalmology, visco supplementation in orthopedy and medical esthetics, announced today an agreement with WAKAMOTO PHARMACEUTICAL CO., LTD. (hereinafter refer to "WAKAMOTO PHARMACEUTICAL") to provide new treatments for cataract surgeries in Japan. The agreement includes a licensing arrangement with WAKAMOTO PHARMACEUTICAL to develop and […]
continue reading
VSY Biotechnology provides the best vision to people worldwide and supplies the best technology to ophthalmologists. The company’s Pre-loaded IOL System Patent has been granted by the Japan Patent Office. VSY Biotechnology’s innovations are indeed for the comfort of everyone in the world. VSY Biotechnology GmbH, an innovation-driven company with its progressive R&D activities in […]
continue reading
VSY Biotechnology Introduces Protectalon DUO Kit, demonstrating commitment to Ophthalmic Surgery! Eye Care Professionals meet their OVD needs at different stages of cataract surgery with a single kit. It is available now for safe, fast and smooth surgery! SPECIFICATIONS: Dual Pack containing one unit cohesive and one unit dispersive OVDs High Filling Volume (1.1 ml Cohesive […]
continue readingVSY Biotechnology GmbH, an innovation-driven company with progressive R&D activities in ophthalmology, has announced the winners of the 2020 Ophthalmology Star Awards. This year’s “Ophthalmology Star Award” is dedicated to Dr. Li Wenliang, an an ophthalmologist who was the first to raise the alarm about COVID-19. Ophthalmologists applied for the contest with their articles until […]
continue reading
VSY Biotechnology announced that it is moving its headquarters from the Netherlands to Germany. VSY Biotechnology GmbH will be the company’s new headquarters. VSY Biotechnology commenced operations in the late 90s. Since then, the company has achieved several milestones on the way to becoming a global player in the innovation-driven medical device sector. VSY […]
continue reading
As part of the Ophthalmology Star Awards (OSA), articles by ophthalmologists published in English since January 2019 are being evaluated by an international jury. Ophthalmologists can apply for the contest until July 15, 2020, from the OSA page (https://www.vsybiotechnology.com/…) on the VSY Biotechnology website. The names of the finalists will be announced at the VSY […]
continue reading